Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry’s, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent company Unilever plc‘s (NYSE:UL) ice cream division. What Happened: The duo, both 73, believe that people’s relationship with ice cream is more about enjoyment and celebration than nutrition, reported The Wall Street Journal. This comes at a time when pharmaceutical companies like Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are introducing weight-loss drugs like Ozempic and Zepbound, r…